The Times Of India Science
Ebola virus in survivors can trigger outbreaks years after infection
Ebola survivors can relapse and trigger outbreaks at least five years after infection, and long-term follow-up of former patients is needed to prevent devastating flare-ups, according to new research. Scientists already knew Ebola could lie dormant in survivors, who test negative because the virus is in tissue rather than circulating in the blood.
In a first, space dept signs pact with Hyderabad startup to provide access to Isro facilities
With the objective to woo private players in space activities, the department of space (DoS) has signed its first-ever agreement with a Hyderabad-based space startup, Skyroot Aerospace, for providing it “access to Isro’s facilities and expertise towards the development and testing of subsystems and systems of space launch vehicles”.
Study suggests Delta does not cause more severe childhood Covid
US pediatric Covid hospitalizations have surged since Delta became predominant, but a new study that offers a first look at the relevant data suggests that fears the variant causes more severe disease are unfounded. The paper by the Centers for Disease Control and Prevention also found that between June 20 and July 31, 2021, unvaccinated adolescents were more than 10 times more likely to be hospitalized than those who were vaccinated.
New clues regarding formation of solar system discovered
A region of active star formation in the constellation Ophiuchus is giving astronomers new insights into the conditions in which our own solar system was born. The findings of the study were published in the journal 'Nature Astronomy'. In particular, the study showed how our solar system may have become enriched with short-lived radioactive elements.
Scientists identify antibodies to develop pan-coronavirus vaccine
Scientists have discovered human antibodies that can neutralise several different coronaviruses and pave the way for a pan-coronavirus vaccine. These antibodies have been detected in some people who have recovered from Covid-19, said the team at University of Washington. The study describes research on five such human monoclonal antibodies that can cross-react with a number of beta-coronaviruses.